A patient undergoing cochlear implant surgery refuses to allow tracking of the device. What is the appropriate action?

Prepare for the CNOR Test: Study with flashcards and multiple choice questions. Each question includes hints and explanations. Get ready for your exam!

Multiple Choice

A patient undergoing cochlear implant surgery refuses to allow tracking of the device. What is the appropriate action?

Explanation:
Respecting the patient’s right to refuse is the guiding principle here. Some implanted devices require post‑implant tracking for safety and regulatory reasons, but a patient can opt out of that tracking. The perioperative nurse’s job is to ensure that this refusal is clearly documented in the surgical record and that the rest of the team is aware of the patient’s decision. If the surgeon agrees that proceeding with the implantation is appropriate despite the tracking refusal, the operation can continue and the note should reflect that tracking was declined. This approach maintains patient autonomy, avoids unnecessary delays, and keeps the record accurate for post‑operative surveillance. Reporting to the FDA isn’t warranted based solely on a patient’s refusal to allow tracking, since there’s no adverse event or regulatory threshold being met by the refusal itself. Canceling the procedure solely for refusal would undermine patient choice and disrupt care.

Respecting the patient’s right to refuse is the guiding principle here. Some implanted devices require post‑implant tracking for safety and regulatory reasons, but a patient can opt out of that tracking. The perioperative nurse’s job is to ensure that this refusal is clearly documented in the surgical record and that the rest of the team is aware of the patient’s decision. If the surgeon agrees that proceeding with the implantation is appropriate despite the tracking refusal, the operation can continue and the note should reflect that tracking was declined. This approach maintains patient autonomy, avoids unnecessary delays, and keeps the record accurate for post‑operative surveillance.

Reporting to the FDA isn’t warranted based solely on a patient’s refusal to allow tracking, since there’s no adverse event or regulatory threshold being met by the refusal itself. Canceling the procedure solely for refusal would undermine patient choice and disrupt care.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy